0363-0875 NDC - WALGREENS EFFERVESCENT COLD RELIEF PLUS ()

Drug Information

  • Product NDC: 0363-0875
  • Proprietary Name: Walgreens Effervescent Cold Relief Plus
  • Non Proprietary Name:
  • Active Ingredient(s): 325 mg/1 ASPIRIN; 2 mg/1 CHLORPHENIRAMINE MALEATE; 7.8 mg/1 PHENYLEPHRINE BITARTRATE
  • Administration Route(s):
  • Dosage Form(s):
  • Pharmacy Class(es): Adrenergic alpha1-Agonists [MoA]; Anti-Inflammatory Agents; Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; alpha-1 Adrenergic Agonist [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Walgreens
Product Type:
FDA Application Number: part341
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date:10/24/2014
End Marketing Date:12/31/2021

Package Information

No. Package Code Package Description Billing Unit
10363-0875-2424 POUCH in 1 CARTON (0363-0875-24) / 2 TABLET, EFFERVESCENT in 1 POUCH
20363-0875-3618 POUCH in 1 CARTON (0363-0875-36) / 2 TABLET, EFFERVESCENT in 1 POUCH

NDC Record

Field Name Field Value Definition
PRODUCT NDC0363-0875The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEWalgreens Effervescent Cold Relief PlusThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE10/24/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH FINALProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERpart341This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEWalgreensName of Company corresponding to the labeler code segment of the Product NDC.
PRODUCT NDC0363-0875The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PROPRIETARY NAMEWalgreens Effervescent Cold Relief PlusThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
START MARKETING DATE10/24/2014This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEOTC MONOGRAPH DRUGProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERM012This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMEWalgreensName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 5/9/2025

Previous Code
Next Code